Practical approach using an RBM framework to develop site risk profiles

While centralized monitoring is starting to be adopted within the bio-pharma industry, there remain questions about whether over reliance on data driven decisions, with less attention paid to the observations of the on-site monitors, will lead to erroneous risk assessment … Read More